These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31176593)

  • 1. Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):233-238. PubMed ID: 31176593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
    Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS
    Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition.
    Nakada T; Kudo T; Ito K
    Drug Metab Dispos; 2023 Sep; 51(9):1114-1126. PubMed ID: 36859345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
    Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
    J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.
    Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S
    Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):103-110. PubMed ID: 29361388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.
    Mathialagan S; Rodrigues AD; Feng B
    J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat.
    Kikuchi R; Chiou WJ; Kasai MA; de Morais SM; Bow DAJ
    J Pharm Sci; 2019 Sep; 108(9):3118-3123. PubMed ID: 31034908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
    Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of
    Miyake T; Mizuno T; Takehara I; Mochizuki T; Kimura M; Matsuki S; Irie S; Watanabe N; Kato Y; Ieiri I; Maeda K; Ando O; Kusuhara H
    Drug Metab Dispos; 2019 Nov; 47(11):1270-1280. PubMed ID: 31511257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells.
    Mathialagan S; Chung G; Pye K; Rodrigues AD; Varma MVS; Brown C
    J Pharmacol Exp Ther; 2024 Jan; 388(1):201-208. PubMed ID: 37977812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
    Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
    Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
    Chu X; Bleasby K; Chan GH; Nunes I; Evers R
    Drug Metab Dispos; 2016 Sep; 44(9):1498-509. PubMed ID: 26825641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management.
    Gutiérrez F; Fulladosa X; Barril G; Domingo P
    AIDS Rev; 2014; 16(4):199-212. PubMed ID: 25350530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.
    Hibma JE; Zur AA; Castro RA; Wittwer MB; Keizer RJ; Yee SW; Goswami S; Stocker SL; Zhang X; Huang Y; Brett CM; Savic RM; Giacomini KM
    Clin Pharmacokinet; 2016 Jun; 55(6):711-21. PubMed ID: 26597253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression.
    Shen H; Liu T; Morse BL; Zhao Y; Zhang Y; Qiu X; Chen C; Lewin AC; Wang XT; Liu G; Christopher LJ; Marathe P; Lai Y
    Drug Metab Dispos; 2015 Jul; 43(7):984-93. PubMed ID: 25904762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearance.
    Shen H; Yang Z; Zhao W; Zhang Y; Rodrigues AD
    Drug Metab Dispos; 2013 Dec; 41(12):2095-103. PubMed ID: 24026623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.